COAST Therapy in Advanced Solid Tumors and Prostate Cancer
for
Prostate Cancer Recurrent, Solid Tumor, Adult
Location: Charleston SC
Sponsor: Medical University of South Carolina
Sex: All
Age: 18+
Code: NCT05036226
Phase1, Phase2, Recruiting
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)
for
PSMA PET-Positive Castration-Resistant Prostate Cancer
Location: Boston MA, New York NY, Durham NC, Cleveland OH,
Sponsor: Convergent Therapeutics
Sex: Male
Age: 18+
Code: NCT06549465
Phase2, Recruiting
Interested in new prostate cancer trials?
Get alerts for new trials in your area by subscribing now
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
for
Prostate Cancer
Location: Boston MA, Ottawa, Toronto, London, Ann Arbor MI,
Sponsor: University of British Columbia
Sex: Male
Age: 18+
Code: NCT04812366
Phase2, Recruiting
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
for
Prostate Cancer
Location: New York NY, Cleveland OH
Sponsor: Weill Medical College of Cornell University
Sex: Male
Age: 18+
Code: NCT05948657
Recruiting
High Intensity Focused Ultrasound in Prostate Cancer
for
Prostate Cancer
Location: Gainesville FL
Sponsor: University of Florida
Sex: Male
Age: 18+
Code: NCT06402357
Phase2, Recruiting
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
for
Small Cell Lung Cancer (SCLC),
Location: Boston MA, New Haven CT, Baltimore MD, Fairfax VA,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05652686
Phase1, Phase2, Recruiting
Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer